Contact Molecules for Homologous Proteins | ||||
![]() [Full Bars] |
![]() [SiteTable] |
|
![]() [Back to Search Page] |
![]() [Back to HOMCOS] |
![]() [help] |
seq_id(%): [0] [30] [40] [50] [60] [70] [80] [90] [95] [100] | ![]() [show] [download] [help] |
PID | QueryLength | Homolgous Sequence in PDB | UniProt Query | TITLE |
1704685 | 925 | 205 | O95786(RIGI_HUMAN) | RecName: Full=Antiviral innate immune response receptor RIG-I ;AltName: Full=ATP-dependent RNA helicase DDX58 ; EC=3.6.4.13 ;AltName: Full=DEAD box protein 58;AltName: Full=RIG-I-like receptor 1; Short=RLR-1;AltName: Full=RNA sensor RIG-I ;AltName: Full=Retinoic acid-inducible gene 1 protein; Short=RIG-1;AltName: Full=Retinoic acid-inducible gene I protein; Short=RIG-I; |
QUERYSEQ |
MTTEQRRSLQAFQDYIRKTLDPTYILSYMAPWFREEEVQYIQAEKNNKGPMEAATLFLKFLLELQEEGWFRGFLDALDHAGYSGLYEAIESWDFKKIEKLEEYRLLLKRLQPEFKTRIIPTDIISDLSECLINQECEEILQICSTKGMMA GAEKLVECLLRSDKENWPKTLKLALEKERNKFSELWIVEKGIKDVETEDLEDKMETSDIQIFYQEDPECQNLSENSCPPSEVSDTNLYSPFKPRNYQLELALPAMKGKNTIICAPTGCGKTFVSLLICEHHLKKFPQGQKGKVVFFANQI PVYEQQKSVFSKYFERHGYRVTGISGATAENVPVEQIVENNDIIILTPQILVNNLKKGTIPSLSIFTLMIFDECHNTSKQHPYNMIMFNYLDQKLGGSSGPLPQVIGLTASVGVGDAKNTDEALDYICKLCASLDASVIATVKHNLEELE QVVYKPQKFFRKVESRISDKFKYIIAQLMRDTESLAKRICKDLENLSQIQNREFGTQKYEQWIVTVQKACMVFQMPDKDEESRICKALFLYTSHLRKYNDALIISEHARMKDALDYLKDFFSNVRAAGFDEIEQDLTQRFEEKLQELESV SRDPSNENPKLEDLCFILQEEYHLNPETITILFVKTRALVDALKNWIEGNPKLSFLKPGILTGRGKTNQNTGMTLPAQKCILDAFKASGDHNILIATSVADEGIDIAQCNLVILYEYVGNVIKMIQTRGRGRARGSKCFLLTSNAGVIEK EQINMYKEKMMNDSILRLQTWDEAVFREKILHIQTHEKFIRDSQEKPKPVPDKENKKLLCRKCKALACYTADVRVIEECHYTVLGDAFKECFVSRPHPKPKQFSSFEKRAKIFCARQNCSHDWGIHVKYKTFEIPVIKIESFVVEDIATG VQTLYSKWKDFHFEKIPFDPAEMSK |
925 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
region | name | description |
![]() |
1-925 | CHAIN | /note="Antiviral innate immune response receptor RIG-I" /id="PRO_0000144093" |
![]() ![]() |
1-87 | DOMAIN | /note="CARD 1" |
![]() ![]() ![]() |
92-172 | DOMAIN | /note="CARD 2" |
![]() ![]() ![]() |
251-430 | DOMAIN | /note="Helicase ATP-binding" |
![]() ![]() ![]() |
610-776 | DOMAIN | /note="Helicase C-terminal" |
![]() ![]() |
794-925 | DOMAIN | /note="RLR CTR" |
![]() ![]() |
218-925 | REGION | /note="Interaction with ZC3HAV1" |
![]() ![]() |
735-925 | REGION | /note="Mediates interaction with RNF135" |
![]() ![]() ![]() |
264-271 | BINDING | /ligand="ATP" /ligand_id="ChEBI:CHEBI:30616" |
![]() ![]() ![]() |
810-810 | BINDING | /ligand="Zn(2+)" /ligand_id="ChEBI:CHEBI:29105" |
![]() ![]() ![]() |
813-813 | BINDING | /ligand="Zn(2+)" /ligand_id="ChEBI:CHEBI:29105" |
![]() ![]() ![]() |
864-864 | BINDING | /ligand="Zn(2+)" /ligand_id="ChEBI:CHEBI:29105" |
![]() ![]() ![]() |
869-869 | BINDING | /ligand="Zn(2+)" /ligand_id="ChEBI:CHEBI:29105" |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
1-925 | DISORDER | predicted by DISOPRED |
![]() |
|||||||
925 | |||||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
pdb_id | a1 | identity[%]2 | description | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 100.0 | DDX58_HUMAN Antiviral innate immune response receptor RIG-I | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 55.7 | D3TI84_ANAPL RETINOIC ACID INDUCIBLE PROTEIN I | |||
1.a1:asym_id for the homologue. 2.identity[%]2:sequence identity between the query and the homologue. |
![]() |
|||||||
925 | pdb_id | contact mol | homologue | ||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
a3 | description | a4 | identity[%]5 | Ncon6 | description | |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | RN135_HUMAN E3 ubiquitin-protein ligase RNF135[171 aa] | A | 100.0 /100.0 |
10 /10 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() |
![]() |
D | RN135_HUMAN E3 ubiquitin-protein ligase RNF135[169 aa] | A | 100.0 /100.0 |
1 /1 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | UBC_HUMAN Ubiquitin[72 aa] | A | 100.0 /100.0 |
5 /5 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | UBC_HUMAN Ubiquitin[73 aa] | A | 100.0 /100.0 |
9 /9 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | UBC_HUMAN Ubiquitin[73 aa] | B | 100.0 /100.0 |
11 /11 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() |
![]() |
Q | RL40_HUMAN Ubiquitin-60S ribosomal protein L40[73 aa] | H | 100.0 /99.5 |
1 /1 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | MAVS_HUMAN Mitochondrial antiviral-signaling protein[97 aa] | A | 100.0 /99.5 |
11 /11 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | MAVS_HUMAN Mitochondrial antiviral-signaling protein[97 aa] | B | 100.0 /99.5 |
6 /6 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() |
![]() |
I | MAVS_HUMAN Mitochondrial antiviral-signaling protein[97 aa] | C | 100.0 /99.5 |
1 /1 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | MAVS_HUMAN Mitochondrial antiviral-signaling protein[97 aa] | D | 100.0 /99.5 |
9 /9 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | TRI65_HUMAN Tripartite motif-containing protein 65[180 aa] | C | 33.3 /40.2 |
9 /11 |
IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | V_SV5 Non-structural protein V[52 aa] | A | 44.0 /37.6 |
25 /26 |
A7LCX1_PIG A7LCX1_PIG Melanoma differentiation associated protein-5 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | Q9VLW8_DROME R2D2[260 aa] | A | 100.0 /32.5 |
1 /43 |
A1ZAW0_DROME Dicer-2, isoform A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | G0SFL3_CHATD Putative pre-mRNA splicing factor[266 aa] | B | 28.6 /31.9 |
7 /57 |
G0S0B9_CHATD Pre-mRNA splicing helicase-like protein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | M9MRT5_DROME Loquacious, isoform D[16 aa] | A | 33.3 /29.7 |
21 /27 |
A1ZAW0_DROME Dicer-2, isoform A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | M9MRT5_DROME Loquacious, isoform D[13 aa] | E | 34.8 /29.7 |
23 /25 |
A1ZAW0_DROME Dicer-2, isoform A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Q9VLW8_DROME LD06392p[126 aa] | A | 19.0 /29.7 |
21 /31 |
A1ZAW0_DROME Dicer-2, isoform A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Q9VLW8_DROME LD06392p[126 aa] | D | 20.0 /29.7 |
5 /11 |
A1ZAW0_DROME Dicer-2, isoform A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | M9MRT5_DROME Loquacious, isoform D[16 aa] | A | 31.6 /29.7 |
19 /23 |
A1ZAW0_DROME Dicer-2, isoform A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Q9VJY9_DROME Loquacious, isoform B[253 aa] | A | 0.0 /24.1 |
3 /55 |
DCR1_DROME Endoribonuclease Dcr-1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | Q9VJY9_DROME Loquacious, isoform B[181 aa] | A | 0.0 /23.7 |
3 /46 |
DCR1_DROME Endoribonuclease Dcr-1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | Q9VJY9_DROME Loquacious, isoform B[108 aa] | A | 0.0 /23.7 |
2 /23 |
DCR1_DROME Endoribonuclease Dcr-1 |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
![]() |
|||||||
925 | pdb_id | contact mol | homologue | ||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
a3 | description | a4 | identity[%]5 | Ncon6 | description | |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 5'-R(*(GDP)P*AP*CP*GP*CP*UP*AP*GP*CP*GP*UP*C)-3' | A | 100.0 /100.0 |
13 /13 |
DDX58_HUMAN RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 5'-R(*(GDP)P*AP*CP*GP*CP*UP*AP*GP*CP*GP*UP*C)-3' | A | 100.0 /100.0 |
4 /4 |
DDX58_HUMAN RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (5'-R(*(GDP)P*AP*CP*GP*CP*UP*AP*GP*CP*GP*UP*C).. | A | 100.0 /100.0 |
11 /11 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() |
![]() |
D | RNA (5'-R(*(GDP)P*AP*CP*GP*CP*UP*AP*GP*CP*GP*UP*C).. | A | 100.0 /100.0 |
3 /3 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | RNA (5'-R(*CP*GP*AP*CP*GP*CP*UP*AP*GP*CP*GP*U)-3').. | A | 100.0 /100.0 |
18 /18 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (5'-R(*CP*GP*AP*CP*GP*CP*UP*AP*GP*CP*GP*U)-3').. | A | 100.0 /100.0 |
27 /27 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | RNA (5'-R(P*GP*AP*AP*UP*AP*UP*AP*AP*UP*AP*GP*UP*GP.. | A | 100.0 /100.0 |
40 /40 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | RNA (5'-R(P*AP*AP*UP*AP*UP*AP*AP*UP*AP*GP*UP*GP*AP.. | A | 100.0 /100.0 |
37 /37 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | RNA (5'-R(*GP*GP*UP*AP*GP*AP*CP*GP*CP*UP*UP*CP*GP*.. | B | 100.0 /100.0 |
46 /46 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (5'-R(*GP*AP*CP*GP*CP*UP*AP*GP*CP*GP*UP*C)-3').. | A | 100.0 /100.0 |
11 /11 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() |
![]() |
D | RNA (5'-R(*GP*AP*CP*GP*CP*UP*AP*GP*CP*GP*UP*C)-3').. | A | 100.0 /100.0 |
3 /3 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | RNA (5'-R(P*GP*AP*CP*UP*GP*AP*CP*UP*GP*AP*CP*UP*GP.. | C | 60.0 /40.2 |
10 /11 |
IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | dsRNA strand 1 | A | 100.0 /100.0 |
17 /17 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | RNA (5'-R(P*UP*CP*AP*GP*UP*CP*AP*GP*UP*CP*AP*GP*UP.. | C | 71.4 /40.2 |
21 /21 |
IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | dsRNA strand 2 | A | 100.0 /100.0 |
27 /27 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | dsRNA strand1 | A | 100.0 /100.0 |
14 /14 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | dsRNA strand 2 | A | 100.0 /100.0 |
24 /24 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | DNA (41-MER) | A | 100.0 /100.0 |
17 /17 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | p3dsRNAa | A | 100.0 /100.0 |
24 /24 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | p3dsRNAb | A | 100.0 /100.0 |
21 /21 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | p2dsRNA | A | 100.0 /100.0 |
26 /26 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | p2dsRNA | A | 100.0 /100.0 |
29 /29 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | OHdsRNA | A | 100.0 /100.0 |
27 /27 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | OHdsRNA | A | 100.0 /100.0 |
28 /28 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | p3SLR30 | A | 100.0 /100.0 |
41 /41 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | p3SLR30 | A | 100.0 /100.0 |
57 /57 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | p3SLR30 | A | 100.0 /100.0 |
33 /33 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | OHSLR30 | A | 100.0 /100.0 |
48 /48 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | OHSLR30 | A | 100.0 /100.0 |
55 /55 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | RNA (5'-R(*CP*GP*AP*CP*GP*CP*UP*AP*GP*CP*GP*UP*CP*.. | C | 100.0 /99.8 |
19 /19 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | RNA (5'-R(*CP*GP*AP*CP*GP*CP*UP*AP*GP*CP*GP*UP*CP*.. | C | 100.0 /99.8 |
29 /29 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | 5'-R-PPP(GP*GP*CP*GP*CP*GP*GP*CP*UP*UP*CP*GP*GP*CP.. | A | 100.0 /99.7 |
31 /31 |
DDX58_HUMAN PROBABLE ATP-DEPENDENT RNA HELICASE DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | 5'-R(*GP*CP*GP*CP*GP*CP*GP*CP*GP*CP)-3' | A | 100.0 /99.5 |
16 /16 |
DDX58_HUMAN PROBABLE ATP-DEPENDENT RNA HELICASE DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 5'-R(*GP*CP*GP*CP*GP*CP*GP*CP*GP*CP)-3' | A | 100.0 /99.5 |
16 /16 |
DDX58_HUMAN PROBABLE ATP-DEPENDENT RNA HELICASE DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (5'-R(*GP*GP*CP*GP*CP*GP*CP*GP*CP*GP*CP*GP*CP*.. | A | 90.9 /99.2 |
11 /11 |
DDX58_HUMAN ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | RNA (5'-R(*GP*GP*CP*GP*CP*GP*CP*GP*CP*GP*CP*GP*CP*.. | A | 100.0 /99.2 |
4 /4 |
DDX58_HUMAN ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (5'-R(*(GTP)P*GP*CP*GP*CP*GP*CP*GP*CP*GP*CP*GP.. | A | 93.3 /99.2 |
15 /15 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | RNA (5'-R(*(GTP)P*GP*CP*GP*CP*GP*CP*GP*CP*GP*CP*GP.. | A | 100.0 /99.2 |
3 /3 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (5'-R(*(ATP)P*UP*AP*UP*AP*UP*AP*UP*AP*UP*AP*U).. | A | 93.3 /99.2 |
15 /15 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | RNA (5'-R(*(ATP)P*UP*AP*UP*AP*UP*AP*UP*AP*UP*AP*U).. | A | 100.0 /99.2 |
4 /4 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 5'-R(*GP*CP*AP*UP*GP*CP*GP*AP*CP*CP*UP*CP*UP*GP *U.. | A | 28.6 /60.0 |
7 /7 |
D3TI84_ANAPL RETINOIC ACID INDUCIBLE PROTEIN I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 5'-R(*UP*CP*AP*AP*AP*CP*AP*GP*AP*GP*GP*UP*CP*GP *C.. | A | 70.8 /60.0 |
24 /24 |
D3TI84_ANAPL RETINOIC ACID INDUCIBLE PROTEIN I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | 5'-R(*GP*CP*AP*UP*GP*CP*GP*AP*CP*CP*UP*CP*UP*GP *U.. | B | 28.6 /59.7 |
7 /7 |
D3TI84_ANAPL RETINOIC ACID INDUCIBLE PROTEIN I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | 5'-R(*UP*CP*AP*AP*AP*CP*AP*GP*AP*GP*GP*UP*CP*GP *C.. | B | 72.0 /59.7 |
25 /25 |
D3TI84_ANAPL RETINOIC ACID INDUCIBLE PROTEIN I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | 5'-R(*GP*GP*GP*AP*GP*AP*AP*CP*AP*AP*CP*GP*CP*GP)-3.. | A | 88.9 /55.3 |
9 /9 |
D3TI84_ANAPL RETINOIC ACID INDUCIBLE PROTEIN I |
![]() ![]() ![]() ![]() ![]() |
![]() |
E | 5'-R(*GP*GP*GP*AP*GP*AP*AP*CP*AP*AP*CP*GP*CP*GP)-3.. | B | 100.0 /55.3 |
1 /1 |
D3TI84_ANAPL RETINOIC ACID INDUCIBLE PROTEIN I |
![]() ![]() ![]() ![]() ![]() |
![]() |
F | 5'-R(*CP*GP*CP*GP*UP*UP*GP*UP*UP*CP*UP*CP*CP*CP)-3.. | A | 0.0 /55.3 |
2 /2 |
D3TI84_ANAPL RETINOIC ACID INDUCIBLE PROTEIN I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | 5'-R(*CP*GP*CP*GP*UP*UP*GP*UP*UP*CP*UP*CP*CP*CP)-3.. | B | 88.9 /55.3 |
9 /9 |
D3TI84_ANAPL RETINOIC ACID INDUCIBLE PROTEIN I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (5'-R(*AP*UP*CP*CP*GP*CP*GP*GP*CP*CP*CP*U)-3').. | A | 46.2 /41.4 |
13 /14 |
IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | RNA (5'-R(P*AP*GP*GP*GP*CP*CP*GP*CP*GP*GP*AP*U)-3'.. | A | 58.6 /41.4 |
29 /29 |
IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | RNA (44-MER) | C | 53.8 /40.2 |
13 /14 |
IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | RNA (44-MER) | C | 57.1 /40.2 |
21 /21 |
IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | RNA (5'-R(P*GP*UP*CP*AP*AP*GP*CP*CP*GP*AP*GP*GP*AP.. | A | 50.0 /39.0 |
14 /15 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | RNA (5'-R(P*GP*UP*CP*AP*AP*GP*CP*CP*GP*AP*GP*GP*AP.. | A | 33.3 /38.8 |
18 /19 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (5'-R(P*UP*CP*UP*CP*CP*UP*CP*GP*GP*CP*UP*UP*GP.. | A | 65.4 /39.0 |
26 /26 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | RNA (5'-R(P*CP*AP*AP*GP*CP*CP*GP*AP*GP*GP*AP*GP*AP.. | A | 50.0 /38.8 |
16 /18 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (5'-R(P*AP*UP*CP*UP*CP*CP*UP*CP*GP*GP*CP*UP*UP.. | A | 63.6 /38.8 |
22 /22 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | RNA (5'-R(P*UP*CP*CP*AP*UP*GP*CP*GP*CP*AP*UP*GP*AP.. | A | 50.0 /39.6 |
14 /15 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | RNA (5'-R(P*UP*CP*CP*AP*UP*GP*CP*GP*CP*AP*UP*GP*AP.. | A | 50.0 /39.5 |
10 /11 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | RNA (5'-R(P*UP*CP*CP*AP*UP*GP*CP*GP*CP*AP*UP*GP*AP.. | A | 53.3 /39.2 |
15 /15 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | RNA (5'-R(P*UP*CP*CP*AP*UP*GP*CP*GP*CP*AP*UP*GP*AP.. | A | 54.5 /38.6 |
11 /12 |
IFIH1_MOUSE Isoform 2 of Interferon-induced helicase C domain-.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | RNA (5'-R(P*UP*CP*CP*AP*UP*GP*CP*GP*CP*AP*UP*GP*AP.. | A | 0.0 /38.6 |
2 /2 |
IFIH1_MOUSE Isoform 2 of Interferon-induced helicase C domain-.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | RNA (5'-R(P*UP*CP*CP*AP*UP*GP*CP*GP*CP*AP*UP*GP*AP.. | A | 0.0 /38.6 |
2 /2 |
IFIH1_MOUSE Isoform 2 of Interferon-induced helicase C domain-.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (5'-R(P*CP*GP*UP*CP*AP*UP*GP*CP*GP*CP*AP*UP*GP.. | A | 69.2 /39.6 |
26 /26 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (5'-R(P*CP*GP*UP*CP*AP*UP*GP*CP*GP*CP*AP*UP*GP.. | A | 64.0 /39.5 |
25 /25 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (5'-R(P*CP*GP*UP*CP*AP*UP*GP*CP*GP*CP*AP*UP*GP.. | A | 70.4 /39.2 |
27 /27 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (5'-R(P*CP*GP*UP*CP*AP*UP*GP*CP*GP*CP*AP*UP*GP.. | A | 100.0 /38.6 |
1 /1 |
IFIH1_MOUSE Isoform 2 of Interferon-induced helicase C domain-.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | RNA (5'-R(P*CP*AP*AP*GP*CP*CP*GP*AP*GP*GP*AP*GP*AP.. | A | 47.4 /38.8 |
19 /21 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | RNA (5'-R(P*CP*AP*AP*GP*CP*CP*GP*AP*GP*GP*AP*GP*AP.. | A | 47.4 /38.8 |
19 /21 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (5'-R(P*CP*AP*AP*GP*CP*CP*GP*AP*GP*GP*AP*GP*AP.. | A | 44.4 /38.3 |
18 /20 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (5'-R(P*CP*UP*CP*UP*CP*CP*UP*CP*GP*GP*CP*UP*UP.. | A | 58.6 /38.8 |
29 /29 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (5'-R(P*CP*UP*CP*UP*CP*CP*UP*CP*GP*GP*CP*UP*UP.. | A | 60.0 /38.8 |
30 /30 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (5'-R(P*GP*GP*UP*AP*CP*GP*UP*AP*CP*C)-3') | A | 70.3 /35.4 |
37 /37 |
G0YYQ5_CHICK LGP2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | RNA (5'-R(P*GP*GP*UP*AP*CP*GP*UP*AP*CP*C)-3') | A | 45.0 /38.1 |
20 /20 |
D9N195_CHICK Melanoma differentiation associated protein-5 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (5'-R(P*GP*GP*UP*AP*CP*GP*UP*AP*CP*C)-3') | A | 56.7 /38.1 |
30 /30 |
D9N195_CHICK Melanoma differentiation associated protein-5 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (5'-R(P*GP*GP*AP*CP*GP*UP*CP*AP*UP*GP*CP*GP*CP.. | A | 45.0 /38.0 |
20 /20 |
D9N195_CHICK Melanoma differentiation associated protein-5 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (5'-R(P*GP*GP*AP*CP*GP*UP*CP*AP*UP*GP*CP*GP*CP.. | B | 60.0 /37.9 |
30 /30 |
D9N195_CHICK Melanoma differentiation associated protein-5 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | RNA (5'-R(P*GP*GP*GP*AP*CP*GP*UP*CP*AP*UP*GP*CP*GP.. | A | 58.1 /38.0 |
31 /31 |
D9N195_CHICK Melanoma differentiation associated protein-5 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | RNA (5'-R(P*GP*GP*GP*AP*CP*GP*UP*CP*AP*UP*GP*CP*GP.. | B | 47.4 /37.9 |
19 /19 |
D9N195_CHICK Melanoma differentiation associated protein-5 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (5'-R(P*AP*GP*GP*UP*AP*CP*GP*UP*AP*CP*C)-3') | A | 62.1 /37.8 |
29 /29 |
D9N195_CHICK Melanoma differentiation associated protein-5 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | RNA (5'-R(P*GP*GP*UP*AP*GP*CP*GP*CP*UP*AP*CP*C)-3'.. | A | 30.8 /35.9 |
26 /26 |
G0YYQ5_CHICK LGP2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (5'-R(P*GP*GP*UP*AP*GP*CP*GP*CP*UP*AP*CP*C)-3'.. | A | 70.6 /35.9 |
34 /34 |
G0YYQ5_CHICK LGP2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | RNA (5'-R(P*GP*GP*UP*AP*CP*GP*UP*AP*CP*CP*C)-3') | A | 30.8 /35.4 |
26 /26 |
G0YYQ5_CHICK LGP2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | RNA (5'-R(*GPPP*GP*AP*GP*CP*GP*UP*GP*CP*CP*GP*GP*G.. | A | 44.8 /35.1 |
67 /67 |
G0YYQ5_CHICK LGP2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | RNA (5'-R(*GPPP*GP*UP*AP*CP*GP*UP*AP*CP*CP*C)-3') .. | A | 30.8 /34.8 |
26 /26 |
G0YYQ5_CHICK LGP2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (5'-R(*GPPP*GP*UP*AP*CP*GP*UP*AP*CP*C)-3') | A | 69.4 /34.8 |
36 /36 |
G0YYQ5_CHICK LGP2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | RNA (5'-R(*GP*GP*AP*GP*GP*UP*AP*GP*UP*AP*GP*GP*UP*.. | A | 0.0 /33.7 |
1 /1 |
A1ZAW0_DROME Dicer-2, isoform A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | 59-nt precursor of miR-15a | A | 0.0 /33.7 |
1 /15 |
DICER_MOUSE Endoribonuclease Dicer |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (73-mer) | A | 50.0 /32.8 |
4 /31 |
DICER_HUMAN Endoribonuclease Dicer |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (73-mer) | A | 100.0 /32.8 |
2 /27 |
DICER_HUMAN Endoribonuclease Dicer |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (5'-R(P*UP*GP*AP*GP*G)-3') | A | 25.0 /32.5 |
4 /5 |
A1ZAW0_DROME Dicer-2, isoform A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | RNA (5'-R(P*CP*CP*UP*CP*UP*CP*U)-3') | A | 57.1 /32.5 |
7 /8 |
A1ZAW0_DROME Dicer-2, isoform A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | pri-miRNA 166f | A | 26.5 /32.3 |
34 /74 |
DCL1_ARATH Endoribonuclease Dicer homolog 1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | pre-miRNA 166f | A | 25.8 /32.3 |
31 /63 |
DCL1_ARATH Endoribonuclease Dicer homolog 1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 5'-R(*GP*CP*GP*CP*GP*CP*GP*C)-3' | A | 40.0 /31.2 |
15 /15 |
DHX58_HUMAN ATP-dependent RNA helicase DHX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 5'-R(*GP*CP*GP*CP*GP*CP*GP*C)-3' | A | 66.7 /31.2 |
6 /6 |
DHX58_HUMAN ATP-dependent RNA helicase DHX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | ssDNA | A | 23.1 /31.1 |
13 /52 |
A0A0D6HFY2_MYCSM ATP-dependent DNA helicase |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (30-MER) | A | 28.6 /29.7 |
7 /17 |
A1ZAW0_DROME Dicer-2, isoform A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | RNA (32-MER) | A | 50.0 /29.7 |
22 /29 |
A1ZAW0_DROME Dicer-2, isoform A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (35-MER) | A | 18.2 /29.7 |
11 /20 |
A1ZAW0_DROME Dicer-2, isoform A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | RNA (35-MER) | A | 47.6 /29.7 |
21 /29 |
A1ZAW0_DROME Dicer-2, isoform A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | dsRNA | D | 50.0 /29.7 |
20 /37 |
A1ZAW0_DROME Dicer-2, isoform A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | dsRNA | D | 25.0 /29.7 |
8 /22 |
A1ZAW0_DROME Dicer-2, isoform A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | dsRNA | C | 30.0 /29.7 |
10 /38 |
A1ZAW0_DROME Dicer-2, isoform A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | dsRNA | C | 45.0 /29.7 |
20 /61 |
A1ZAW0_DROME Dicer-2, isoform A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | siRNA | A | 27.3 /29.7 |
11 /19 |
A1ZAW0_DROME Dicer-2, isoform A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | siRNA | A | 47.4 /29.7 |
19 /32 |
A1ZAW0_DROME Dicer-2, isoform A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | RNA (52-MER) | A | 30.0 /29.7 |
10 /15 |
A1ZAW0_DROME Dicer-2, isoform A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | RNA (52-MER) | A | 47.4 /29.7 |
19 /24 |
A1ZAW0_DROME Dicer-2, isoform A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | RNA (5'-R(P*GP*AP*GP*AP*CP*UP*UP*GP*G)-3') | A | 42.9 /29.7 |
7 /13 |
A1ZAW0_DROME Dicer-2, isoform A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | RNA (5'-R(P*CP*CP*AP*AP*GP*UP*CP*UP*CP*UP*U)-3') | A | 50.0 /29.7 |
18 /23 |
A1ZAW0_DROME Dicer-2, isoform A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | RNA (60-MER) | A | 100.0 /24.1 |
1 /79 |
DCR1_DROME Endoribonuclease Dcr-1 |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
![]() |
|||||||
925 | pdb_id | contact mol | homologue | ||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
a3 | description | a4 | identity[%]5 | Ncon6 | description | |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
ADP
|
A | 100.0 /99.4 |
14 /14 |
DDX58_HUMAN PROBABLE ATP-DEPENDENT RNA HELICASE DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
ADP
|
A | 81.8 /39.0 |
11 /13 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B |
ADP
|
A | 71.4 /31.9 |
7 /13 |
G0S0B9_CHATD Pre-mRNA splicing helicase-like protein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
ADP
|
A | 100.0 /31.9 |
1 /13 |
G0S0B9_CHATD Pre-mRNA splicing helicase-like protein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
ADP
|
C | 80.0 /40.2 |
10 /11 |
IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
ADP
|
A | 100.0 /100.0 |
10 /10 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
ADP
|
A | 100.0 /100.0 |
12 /12 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O |
M7G
|
A | 100.0 /100.0 |
7 /7 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q |
GTP
|
A | 100.0 /100.0 |
10 /10 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
GTP
|
A | 100.0 /100.0 |
10 /10 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B |
ANP
|
A | 91.7 /78.8 |
12 /12 |
DDX58_MOUSE RIG-I Helicase Domain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C |
ANP
|
A | 100.0 /31.1 |
6 /17 |
A0A0D6HFY2_MYCSM ATP-dependent DNA helicase |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
ANP
|
A | 77.8 /38.8 |
9 /10 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
ATP
|
A | 77.8 /38.5 |
9 /10 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
AGS
|
A | 75.0 /31.9 |
8 /17 |
G0S0B9_CHATD Pre-mRNA splicing helicase-like protein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
AGS
|
A | 33.3 /31.9 |
3 /16 |
G0S0B9_CHATD Pre-mRNA splicing helicase-like protein |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
![]() |
|||||||
925 | pdb_id | contact mol | homologue | ||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
a3 | description | a4 | identity[%]5 | Ncon6 | description | |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
ZN
|
A | 100.0 /100.0 |
4 /4 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B |
ZN
|
A | 83.3 /31.2 |
6 /6 |
DHX58_HUMAN ATP-dependent RNA helicase DHX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B |
ZN
|
A | 80.0 /31.6 |
5 /5 |
IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
ZN
|
A | 100.0 /99.5 |
4 /4 |
DDX58_HUMAN PROBABLE ATP-DEPENDENT RNA HELICASE DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
ZN
|
A | 100.0 /99.2 |
4 /4 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
ZN
|
A | 100.0 /100.0 |
4 /4 |
DDX58_HUMAN RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
ZN
|
A | 100.0 /99.2 |
4 /4 |
DDX58_HUMAN ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C |
ZN
|
A | 100.0 /99.7 |
4 /4 |
DDX58_HUMAN PROBABLE ATP-DEPENDENT RNA HELICASE DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
ZN
|
A | 100.0 /99.5 |
4 /4 |
DDX58_HUMAN PROBABLE ATP-DEPENDENT RNA HELICASE DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
ZN
|
A | 80.0 /41.4 |
5 /5 |
IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
ZN
|
A | 100.0 /35.4 |
4 /4 |
G0YYQ5_CHICK LGP2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
ZN
|
A | 100.0 /34.8 |
4 /4 |
G0YYQ5_CHICK LGP2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
ZN
|
A | 100.0 /38.8 |
4 /4 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
ZN
|
C | 100.0 /99.8 |
5 /5 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
ZN
|
A | 100.0 /38.3 |
5 /5 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
ZN
|
A | 80.0 /38.6 |
5 /5 |
IFIH1_MOUSE Isoform 2 of Interferon-induced helicase C domain-.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
ZN
|
C | 100.0 /40.2 |
4 /4 |
IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
ZN
|
A | 100.0 /100.0 |
4 /4 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
ZN
|
A | 100.0 /100.0 |
4 /4 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
MG
|
A | 100.0 /99.4 |
2 /2 |
DDX58_HUMAN PROBABLE ATP-DEPENDENT RNA HELICASE DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
MG
|
A | 100.0 /60.0 |
5 /5 |
D3TI84_ANAPL RETINOIC ACID INDUCIBLE PROTEIN I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
MG
|
A | 100.0 /99.7 |
3 /3 |
DDX58_HUMAN PROBABLE ATP-DEPENDENT RNA HELICASE DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
MG
|
A | 100.0 /100.0 |
2 /2 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() |
![]() |
F |
MG
|
A | 100.0 /100.0 |
1 /1 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
MG
|
A | 100.0 /100.0 |
2 /2 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N |
MG
|
A | 100.0 /100.0 |
2 /2 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() |
![]() |
N |
MG
|
A | 100.0 /100.0 |
1 /1 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() |
![]() |
N |
MG
|
A | 100.0 /100.0 |
4 /4 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O |
MG
|
A | 100.0 /100.0 |
2 /2 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() |
![]() |
P |
MG
|
A | 100.0 /100.0 |
1 /1 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() |
![]() |
U |
MG
|
E | 100.0 /100.0 |
1 /1 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
X |
MG
|
G | 100.0 /100.0 |
2 /2 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
MG
|
A | 100.0 /35.4 |
2 /2 |
G0YYQ5_CHICK LGP2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
MG
|
A | 100.0 /34.8 |
2 /2 |
G0YYQ5_CHICK LGP2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
MG
|
A | 0.0 /34.8 |
1 /1 |
G0YYQ5_CHICK LGP2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
MG
|
A | 100.0 /31.1 |
3 /3 |
A0A0D6HFY2_MYCSM ATP-dependent DNA helicase |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
MG
|
A | 100.0 /39.0 |
1 /1 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
MG
|
C | 100.0 /99.8 |
2 /2 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
MG
|
A | 100.0 /38.3 |
1 /1 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
MG
|
C | 100.0 /40.2 |
1 /1 |
IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
F |
MG
|
A | 100.0 /100.0 |
1 /1 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() |
![]() |
D |
MG
|
A | 100.0 /100.0 |
2 /2 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() |
![]() |
G |
CL
|
B | 100.0 /100.0 |
2 /2 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
CL
|
A | 66.7 /76.5 |
3 /3 |
DDX58_MOUSE Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() |
![]() |
H |
CL
|
A | 100.0 /76.5 |
1 /1 |
DDX58_MOUSE Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
CL
|
D | 0.0 /76.5 |
3 /3 |
DDX58_MOUSE Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B |
NA
|
A | 100.0 /51.0 |
5 /5 |
IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
MN
|
A | 100.0 /31.9 |
2 /2 |
G0S0B9_CHATD Pre-mRNA splicing helicase-like protein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
HG
|
A | 100.0 /100.0 |
4 /4 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
HG
|
A | 100.0 /31.5 |
4 /4 |
DHX58_HUMAN PROBABLE ATP-DEPENDENT RNA HELICASE DHX58 |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
![]() |
|||||||
925 | pdb_id | contact mol | homologue | ||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
a3 | description | a4 | identity[%]5 | Ncon6 | description | |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58[495 aa] | A | 100.0 /100.0 |
40 /40 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58[648 aa] | A | 100.0 /100.0 |
20 /20 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58[641 aa] | A | 100.0 /100.0 |
26 /26 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() |
![]() |
G | DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58[647 aa] | A | 100.0 /100.0 |
1 /1 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() |
![]() |
K | DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58[644 aa] | A | 100.0 /100.0 |
3 /3 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58[647 aa] | C | 100.0 /100.0 |
11 /11 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K | DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58[644 aa] | C | 100.0 /100.0 |
3 /3 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | DDX58_HUMAN Antiviral innate immune response receptor RIG-I[65.. | A | 100.0 /100.0 |
7 /7 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | DDX58_HUMAN Antiviral innate immune response receptor RIG-I[65.. | A | 100.0 /100.0 |
6 /6 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58[188 aa] | A | 100.0 /100.0 |
21 /21 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58[188 aa] | A | 100.0 /100.0 |
12 /12 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58[188 aa] | A | 100.0 /99.5 |
3 /3 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() |
![]() |
H | DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58[188 aa] | A | 100.0 /99.5 |
2 /2 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | DDX58_MOUSE Probable ATP-dependent RNA helicase DDX58[191 aa] | A | 82.4 /76.5 |
17 /17 |
DDX58_MOUSE Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | DDX58_MOUSE Probable ATP-dependent RNA helicase DDX58[189 aa] | A | 72.7 /76.5 |
22 /22 |
DDX58_MOUSE Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. | C | 0.0 /40.2 |
9 /9 |
IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. | C | 0.0 /40.2 |
7 /9 |
IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | IFIH1_MOUSE Isoform 2 of Interferon-induced helicase C domain-.. | A | 10.0 /38.6 |
10 /11 |
IFIH1_MOUSE Isoform 2 of Interferon-induced helicase C domain-.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | IFIH1_MOUSE Isoform 2 of Interferon-induced helicase C domain-.. | A | 14.3 /38.6 |
7 /13 |
IFIH1_MOUSE Isoform 2 of Interferon-induced helicase C domain-.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | D9N195_CHICK Melanoma differentiation associated protein-5[647 .. | A | 35.0 /38.0 |
20 /21 |
D9N195_CHICK Melanoma differentiation associated protein-5 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | DHX58_HUMAN ATP-dependent RNA helicase DHX58[142 aa] | A | 0.0 /31.2 |
2 /2 |
DHX58_HUMAN ATP-dependent RNA helicase DHX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | A1ZAW0_DROME Dicer-2, isoform A[1478 aa] | A | 46.4 /29.7 |
28 /55 |
A1ZAW0_DROME Dicer-2, isoform A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | A1ZAW0_DROME Dicer-2, isoform A[660 aa] | D | 0.0 /29.7 |
1 /6 |
A1ZAW0_DROME Dicer-2, isoform A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | A1ZAW0_DROME Dicer-2, isoform A[1544 aa] | E | 0.0 /29.7 |
2 /8 |
A1ZAW0_DROME Dicer-2, isoform A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | A1ZAW0_DROME Dicer-2, isoform A[1561 aa] | D | 40.0 /29.7 |
5 /13 |
A1ZAW0_DROME Dicer-2, isoform A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | A1ZAW0_DROME Dicer-2, isoform A[1561 aa] | A | 0.0 /29.7 |
7 /28 |
A1ZAW0_DROME Dicer-2, isoform A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | A1ZAW0_DROME Dicer-2, isoform A[1561 aa] | D | 33.3 /29.7 |
6 /31 |
A1ZAW0_DROME Dicer-2, isoform A |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
![]() |
|||||||
925 | pdb_id | contact mol | homologue | ||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
a3 | description | a4 | identity[%]5 | Ncon6 | description | |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
BEF
|
A | 100.0 /100.0 |
5 /5 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O |
ETF
|
A | 100.0 /100.0 |
9 /9 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Y |
ETF
|
E | 100.0 /100.0 |
5 /5 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
CA |
ETF
|
G | 100.0 /100.0 |
5 /5 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
NA |
ETF
|
K | 100.0 /100.0 |
6 /6 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P |
BU3
|
A | 100.0 /100.0 |
7 /7 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q |
BU3
|
A | 100.0 /100.0 |
5 /5 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
U |
BU3
|
A | 100.0 /100.0 |
5 /5 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
T |
BU3
|
C | 100.0 /100.0 |
4 /4 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
V |
BU3
|
C | 100.0 /100.0 |
4 /4 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
W |
BU3
|
C | 100.0 /100.0 |
8 /8 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
AA |
BU3
|
E | 100.0 /100.0 |
9 /9 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
EA |
BU3
|
G | 100.0 /100.0 |
5 /5 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C |
EDO
|
A | 100.0 /78.8 |
7 /7 |
DDX58_MOUSE RIG-I Helicase Domain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
EDO
|
A | 60.0 /35.4 |
5 /5 |
G0YYQ5_CHICK LGP2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
EDO
|
A | 50.0 /35.4 |
4 /5 |
G0YYQ5_CHICK LGP2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
EDO
|
A | 50.0 /35.4 |
6 /6 |
G0YYQ5_CHICK LGP2 |
![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
EDO
|
A | 100.0 /76.5 |
2 /2 |
DDX58_MOUSE Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() |
![]() |
I |
EDO
|
B | 100.0 /76.5 |
1 /3 |
DDX58_MOUSE Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
EDO
|
B | 100.0 /76.5 |
2 /2 |
DDX58_MOUSE Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
EDO
|
C | 75.0 /76.1 |
4 /4 |
DDX58_MOUSE Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
AF3
|
A | 100.0 /60.0 |
9 /9 |
D3TI84_ANAPL RETINOIC ACID INDUCIBLE PROTEIN I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
ALF
|
A | 100.0 /35.4 |
8 /8 |
G0YYQ5_CHICK LGP2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
ALF
|
A | 100.0 /34.8 |
8 /8 |
G0YYQ5_CHICK LGP2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
ALF
|
A | 100.0 /39.0 |
6 /6 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
ALF
|
C | 100.0 /40.2 |
6 /6 |
IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
ALF
|
A | 100.0 /100.0 |
5 /5 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
MGF
|
A | 0.0 /35.4 |
1 /1 |
G0YYQ5_CHICK LGP2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
SO4
|
A | 0.0 /31.5 |
3 /3 |
DHX58_HUMAN PROBABLE ATP-DEPENDENT RNA HELICASE DHX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
SO4
|
C | 25.0 /31.9 |
4 /4 |
DHX58_HUMAN PROBABLE ATP-DEPENDENT RNA HELICASE DHX58 |
![]() ![]() ![]() ![]() ![]() |
![]() |
E |
SO4
|
A | 100.0 /99.5 |
7 /7 |
DDX58_HUMAN PROBABLE ATP-DEPENDENT RNA HELICASE DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B |
SO4
|
A | 100.0 /36.8 |
1 /1 |
IFIH1_MOUSE IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
SO4
|
A | 25.0 /36.8 |
4 /4 |
IFIH1_MOUSE IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
SO4
|
A | 100.0 /100.0 |
4 /4 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() |
![]() |
E |
SO4
|
A | 100.0 /100.0 |
1 /1 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
SO4
|
A | 50.0 /35.1 |
2 /3 |
G0YYQ5_CHICK LGP2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
SO4
|
A | 33.3 /35.1 |
3 /3 |
G0YYQ5_CHICK LGP2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
SO4
|
A | 0.0 /35.1 |
1 /1 |
G0YYQ5_CHICK LGP2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
SO4
|
A | 25.0 /35.1 |
4 /4 |
G0YYQ5_CHICK LGP2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C |
SO4
|
A | 100.0 /31.9 |
5 /5 |
G0S0B9_CHATD Pre-mRNA splicing helicase-like protein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
SO4
|
A | 100.0 /31.9 |
1 /3 |
G0S0B9_CHATD Pre-mRNA splicing helicase-like protein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
ACT
|
B | 83.3 /31.9 |
6 /6 |
G0S0B9_CHATD Pre-mRNA splicing helicase-like protein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C |
GOL
|
A | 66.7 /55.3 |
6 /8 |
D3TI84_ANAPL RETINOIC ACID INDUCIBLE PROTEIN I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
GOL
|
A | 66.7 /55.3 |
3 /3 |
D3TI84_ANAPL RETINOIC ACID INDUCIBLE PROTEIN I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
GOL
|
A | 100.0 /100.0 |
5 /5 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
GOL
|
A | 0.0 /31.1 |
3 /9 |
A0A0D6HFY2_MYCSM ATP-dependent DNA helicase |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
A | 50.0 /31.1 |
2 /4 |
A0A0D6HFY2_MYCSM ATP-dependent DNA helicase |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
PEG
|
A | 33.3 /31.1 |
3 /5 |
A0A0D6HFY2_MYCSM ATP-dependent DNA helicase |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
PO4
|
A | 85.7 /29.3 |
7 /7 |
Q8TZH8_PYRFU ATP-dependent RNA helicase, putative |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. |